Skip to search.
 FTSE 100 Down 0.67%

KaloBios Pharmaceuticals, Inc. (KBIO)

-NasdaqGM
0.49 Down 0.01(1.80%) 2 Jul 21:00
Add to Portfolio
Prev Close:0.50
Open:0.49
Bid:N/A
Ask:0.56 x 1000
1y Target Est:5.00
Beta:4.24
Earnings Date:5 Aug - 10 Aug (Est.)
Day's Range:0.46 - 0.51
52wk Range:0.36 - 2.34
Volume:177,682
Avg Vol (3m):658,743
Market Cap:16.17m
P/E (ttm):N/A
EPS (ttm):-1.13
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for KBIO at this time.

Comparison

Symbol% ChgMkt Cap
KBIODown 1.80%16.17m
VRTXUp 4.02%31.99b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.17
Quarterly EPS Est (Jun-15) :-0.21
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

KaloBios Pharmaceuticals, Inc., a biopharmaceutical company, develops monoclonal antibody therapeutics for the treatment of cancer in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback